ID,author,year,cancerType,cellLine,time,coumarin,coumarinDose,viability,viabilitySD,viabilityN,control,controlSD,controlN
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,16.7,93.61,6.39,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,33.4,85.81,2.13,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,66.8,78.95,8.04,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,133.6,52,11.35,3,85.81,2.13,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,16.7,92.67,4.49,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,33.4,79.9,5.2,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,66.8,53.19,4.49,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,133.6,37.58,5.91,3,96.69,3.31,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,16.7,97.87,1.42,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,33.4,91.48,6.62,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,66.8,60.04,14.19,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,133.6,44.2,5.44,3,92.9,2.84,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,16.7,84.86,5.21,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,33.4,69.97,4.26,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,66.8,65.01,6.43,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,133.6,43.26,3.54,3,90.7,2.12,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,16.7,74.94,11.34,3,92.9,7.1,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,33.4,72.1,10.16,3,92.9,7.1,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,66.8,69.97,6.43,3,92.9,7.1,3
6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,133.6,41.13,5.67,3,92.9,7.1,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,31.49,50,5.83,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,47.93,50,5.83,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,3.13,88.38,6.36,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,6.25,82.32,2.38,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,12.5,71.21,5.57,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,25,55.34,6.1,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,50,41.59,3.44,3,100,3.36,3
8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,100,22.53,0.79,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,3.13,88.35,11.65,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,6.25,85.44,7.41,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,12.5,72.25,19.84,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,25,69.04,5.03,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,50,64.28,9.26,3,100,3.36,3
8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,100,18.78,3.45,3,100,3.36,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,5,93.33,8.23,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,10,94.5,4.7,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,20,92.15,6.66,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,40,85.88,4.7,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,80,65.88,6.27,3,95.68,3.13,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,5,93.72,3.92,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,10,85.88,7.84,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,20,83.13,7.05,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,40,76.86,10.19,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,80,64.31,8.23,3,88.23,8.62,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,5,92.94,7.84,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,10,85.49,10.19,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,20,81.56,3.13,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,40,78.43,6.27,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,80,49.41,1.96,3,81.56,8.23,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,5,86.66,3.92,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,10,81.17,8.62,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,20,77.64,3.13,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,40,73.72,5.88,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,80,42.35,4.31,3,80.78,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,5,79.6,4.7,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,10,76.47,8.23,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,20,73.72,3.13,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,40,70.58,5.09,3,77.25,6.66,3
42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,80,34.9,5.88,3,77.25,6.66,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,16.7,99.25,4.32,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,33.5,100.37,2.47,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,67,99.04,3.7,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,134,97.71,3.09,3,99.38,3.11,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,16.7,103.91,2.47,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,33.5,96.98,3.09,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,67,84.53,3.7,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,134,76.37,4.34,3,103.43,2.47,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,16.7,105.6,9.87,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,33.5,102.49,10.49,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,67,87.02,4.32,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,134,75.27,8.02,3,110.65,8,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,16.7,80.24,7.95,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,33.5,78.18,6.43,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,67,62.05,4.28,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,134,45.63,6.42,3,82.62,6.41,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,16.7,91.8,3.67,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,33.5,82.35,1.83,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,67,60.04,9.48,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,134,47.54,6.12,3,91.46,3.06,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,16.7,88.86,1.83,3,88.2,3.67,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,33.5,78.25,6.41,3,88.2,3.67,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,67,56.34,7.95,3,88.2,3.67,3
44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,134,40.24,1.83,3,88.2,3.67,3
46,Afshari et al.,2019,Glioblastoma,U87,8,Auraptene,167.6,70.16,2.76,3,100,1.65,3
46,Afshari et al.,2019,Glioblastoma,U87,8,Auraptene,335.2,51.93,3.31,3,100,1.65,3
46,Afshari et al.,2019,Glioblastoma,U87,24,Auraptene,167.6,57.91,3.34,3,100,2.09,3
46,Afshari et al.,2019,Glioblastoma,U87,24,Auraptene,335.2,42.5,2.91,3,100,2.09,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,2.5,90.94,4.53,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,5,86.41,4.53,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,10,75.09,7.55,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,20,55.09,16.6,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,40,28.3,2.26,3,99.62,12.45,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,2.5,86.41,9.43,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,5,84.9,19.62,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,10,70.18,19.63,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,20,56.6,3.77,3,100,9.05,3
47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,40,45.66,17.35,3,100,9.05,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,12.5,92.84,13.58,3,100,2.91,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,25,80.73,9.91,3,100,2.91,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,50,48.44,6.23,3,100,2.91,3
48,Moon et al.,2015,Gastric,AGS,48,Auraptene,100,42.2,4.03,3,100,2.91,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,12.5,108.62,21.65,3,100,6.6,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,25,109.35,13.21,3,100,6.6,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,50,67.88,14.68,3,100,6.6,3
48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,100,35.59,3.67,3,100,6.6,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,12.5,66.42,15.78,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,25,44.77,10.27,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,50,29.35,1.47,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,100,29.72,1.1,3,100,3.67,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,12.5,86.97,3.3,3,100,8.07,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,25,84.4,4.4,3,100,8.07,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,50,48.44,3.67,3,100,8.07,3
48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,100,44.03,4.41,3,100,8.07,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,1,89.04,6.18,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,2,98.87,10.68,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,5,100.28,10.67,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,10,68.25,8.99,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,15,25.28,5.33,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,20,18.82,3.93,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,25,15.73,1.96,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,30,15.16,2.53,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,40,16.57,1.96,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,50,17.97,2.53,3,100,9.01,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,1,107.26,4.93,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,2,106.84,6.17,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,5,95.75,4.11,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,10,96.98,6.99,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,15,76.84,4.11,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,20,74.79,5.34,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,25,65.34,5.75,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,30,56.71,5.34,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,40,51.78,4.52,3,100,3.36,3
49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,50,51.36,5.35,3,100,3.36,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,48,Auraptene,10,98.62,1.83,3,99.9,1.76,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,48,Auraptene,20,100,4.3,3,99.9,1.76,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,10,97.8,1.74,3,99.4,1.51,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,20,95.7,4.3,3,99.4,1.51,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,40,79.2,10.7,3,99.4,1.51,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,10,81.2,15.58,3,98.9,2.01,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,20,87.3,3.52,3,98.9,2.01,3
51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,40,76,11.61,3,98.9,2.01,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,1,90.2,2.45,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,3,88.73,4.9,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,10,78.93,3.93,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,48,Auraptene,30,52.46,2.46,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,1,87.09,1.44,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,3,84.22,1.44,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,10,57.9,2.87,3,100,3.36,3
52,Li et al.,2013,Breast,T47D,144,Auraptene,30,19.14,1.43,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,1,99.53,3.3,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,3,100,2.8,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,10,98.12,2.82,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,30,87.74,1.89,3,100,3.36,3
52,Li et al.,2013,Breast,MDA-MB231,144,Auraptene,30,71,0.5,3,100,3.36,3
59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,61.3,50,3.65,3,100,3.36,3
59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,103.8,75,4.79,3,100,3.36,3
59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,207.7,49.24,2.52,3,100,3.36,3
60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,12.25,81.44,6.09,6,100,3.36,6
60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,25,75.34,5.54,6,100,3.36,6
60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,50,62.04,5.81,6,100,3.36,6
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,70,50,6.82,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MDA-MB231,48,Auraptene,60,50,6.82,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,0.1,103.26,12.76,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,1,99.11,7.12,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,10,89.91,6.23,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,50,70.91,4.75,2,100,3.36,2
61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,100,26.11,6.82,2,100,3.36,2
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,12.5,105.25,3.94,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,25,106.37,8.45,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,50,84.99,5.34,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,100,75.42,2.53,3,99.9,1.97,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,12.5,80.44,1.59,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,25,61.85,1.86,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,50,50.7,1.86,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,100,38.76,1.59,3,99.82,2.39,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,12.5,76.01,1.75,3,100,2.04,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,25,59.12,2.91,3,100,2.04,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,50,46.89,3.2,3,100,2.04,3
62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,100,42.52,5.53,3,100,2.04,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,15,99.68,2.02,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,30,80.42,7.84,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,60,63.39,3.36,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,90,60.48,2.91,3,100,3.36,3
63,Lee et al.,2017,Prostate,PC3,24,Auraptene,120,43.68,2.46,3,100,3.36,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,15,87.81,3.59,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,30,79.3,1.57,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,60,70.34,1.56,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,90,62.72,3.36,3,100,2.24,3
63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,120,57.34,2.24,3,100,2.24,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,15,72.04,2.31,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,30,60.21,3.58,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,60,56.45,2.33,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,90,41.03,2.28,3,100,2.8,3
63,Lee et al.,2017,Prostate,DU145,24,Auraptene,120,33.15,5.02,3,100,2.8,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,40,89.38,11.02,3,100,3.36,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,80,80.81,2.04,3,100,3.36,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,160,77.55,2.45,3,100,3.36,3
64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,330,46.53,2.45,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,6.25,94.44,2.96,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,12.5,92.59,1.48,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,25,87.03,3.34,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,50,84.07,2.59,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,100,58.14,2.6,3,100,3.36,3
66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,200,41.48,1.48,3,100,3.36,3
38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,10,91,1.4,3,94.68,1.69,3
38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,20,80.27,1.97,3,94.68,1.69,3
38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,50,68.7,2.25,3,94.68,1.69,3
38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,100,51.49,8.16,3,94.68,1.69,3
38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,200,9.22,1.12,3,94.68,1.69,3
38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,10,86.31,1.97,3,97.31,1.97,3
38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,20,76.97,5.35,3,97.31,1.97,3
38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,50,64.56,4.22,3,97.31,1.97,3
38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,100,18.63,1.12,3,97.31,1.97,3
38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,200,9.13,1.4,3,97.31,1.97,3
38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,10,88.65,1.7,3,96.28,2.81,3
38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,20,79.33,4.5,3,96.28,2.81,3
38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,50,57.06,10.99,3,96.28,2.81,3
38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,100,19.56,1.4,3,96.28,2.81,3
38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,200,10.82,2.53,3,96.28,2.81,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,10,94.82,2.01,3,93.1,0.86,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,20,89.36,4.2,3,93.1,0.86,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,50,81.69,3.44,3,93.1,0.86,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,100,54.59,12.93,3,93.1,0.86,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,200,32.18,6.32,3,93.1,0.86,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,10,90.8,3.16,3,91.66,2.29,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,20,87.06,2.58,3,91.66,2.29,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,50,66.09,2.01,3,91.66,2.29,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,100,31.6,10.91,3,91.66,2.29,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,200,10.91,4.31,3,91.66,2.29,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,10,86.2,5.17,3,91.95,2.58,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,20,79.02,6.32,3,91.95,2.58,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,50,72.12,5.45,3,91.95,2.58,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,100,27.58,11.78,3,91.95,2.58,3
38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,200,5.74,2.29,3,91.95,2.58,3
39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,36.4,50,3.615,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,33.6,50,3.615,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,37.1,50,3.615,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,40.8,50,3.615,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,36.04,50,3.615,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,55.8,50,3.615,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,51.9,50,3.615,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,37.9,50,3.615,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,43.6,50,3.615,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,8.1,98.85,3.43,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,16.3,98.28,4,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,32.7,89.92,3.04,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,68.2,71.29,3.42,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,136.4,29.08,2.85,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,272.8,15.39,3.05,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,8.1,99.23,3.05,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,16.3,89.92,3.61,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,32.7,92.38,3.62,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,68.2,64.06,4,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,136.4,25.28,2.85,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,272.8,18.63,2.85,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,8.1,99.04,3.24,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,16.3,95.62,2.09,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,32.7,92.01,2.66,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,68.2,76.8,8.75,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,136.4,28.13,3.99,3,100,2.29,3
39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,272.8,10.83,2.66,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,8.1,100,6.89,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,16.3,97.82,4.72,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,32.7,98.91,4.17,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,68.2,59.52,6.17,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,136.4,41.74,1.99,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,272.8,20.14,1.81,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,8.1,98.91,7.98,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,16.3,98,7.98,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,32.7,93.1,2.35,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,68.2,64.79,1.81,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,136.4,30.82,1.6,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,272.8,16.87,1.99,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,8.1,98.18,8.89,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,16.3,96.37,9.8,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,32.7,94.55,9.8,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,68.2,89.83,6.89,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,136.4,53.72,4.17,3,100,2.29,3
39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,272.8,17.96,2.9,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,8.5,96.54,7.56,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,17,98.28,2.58,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,34,93.02,1.84,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,68.2,71.52,5.37,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,136.4,46.71,11.07,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,272.8,23.55,3.5,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,8.5,100.96,4.24,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,17,96.99,6.08,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,34,90.62,7.56,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,68.2,71.15,5.9,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,136.4,32.05,2.58,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,272.8,10.44,2.02,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,8.5,98.19,10.7,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,17,93.49,7.19,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,34,89.7,11.07,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,68.2,68.57,10.15,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,136.4,41.91,3.32,3,100,2.29,3
39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,272.8,17.83,2.76,3,100,2.29,3
43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,48,Umbelliprenin,20,99.8,4.8,3,99.9,1.96,3
43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,48,Umbelliprenin,40,99.9,4.8,3,99.9,1.96,3
43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,48,Umbelliprenin,80,74.9,3.77,3,99.9,1.96,3
43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,72,Umbelliprenin,20,99.09,1.51,3,99.39,1.51,3
43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,72,Umbelliprenin,40,95.79,4.27,3,99.39,1.51,3
43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,72,Umbelliprenin,80,60.06,12.61,3,99.39,1.51,3
43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,96,Umbelliprenin,1,87.08,14.42,3,98.79,2.41,3
43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,96,Umbelliprenin,40,75.67,24.63,3,98.79,2.41,3
43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,96,Umbelliprenin,80,60.06,4.8,3,98.79,2.41,3
54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,6.25,95.66,1.45,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,12.5,93.85,1.09,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,25,85.51,1.08,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,50,76.82,5.8,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,100,56.89,2.17,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,200,23.56,1.82,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,6.25,95.29,2.53,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,12.5,92.76,1.45,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,25,81.53,2.54,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,50,70.29,2.53,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,100,33.34,1.09,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,200,7.06,1.26,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,6.25,81.53,2.54,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,12.5,75.73,1.81,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,25,69.93,2.17,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,50,53.99,2.9,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,100,36.96,2.9,3,100,2.29,3
54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,200,4.35,1.45,3,100,2.29,3
55,Ziai et al.,2012,Leukemia,Jurkat T,16,Umbelliprenin,10,92.47,1.94,3,100,2.29,3
55,Ziai et al.,2012,Leukemia,Jurkat T,16,Umbelliprenin,25,86.15,3.65,3,100,2.29,3
55,Ziai et al.,2012,Leukemia,Jurkat T,16,Umbelliprenin,50,63.06,2.92,3,100,2.29,3
55,Ziai et al.,2012,Leukemia,Jurkat T,16,Umbelliprenin,100,39.73,2.43,3,100,2.29,3
55,Ziai et al.,2012,Leukemia,Jurkat T,48,Umbelliprenin,10,69.18,2.74,3,100,2.29,3
55,Ziai et al.,2012,Leukemia,Jurkat T,48,Umbelliprenin,25,50.35,3.43,3,100,2.29,3
55,Ziai et al.,2012,Leukemia,Jurkat T,48,Umbelliprenin,50,25.69,3.08,3,100,2.29,3
55,Ziai et al.,2012,Leukemia,Jurkat T,48,Umbelliprenin,100,13.7,3.42,3,100,2.29,3
56,Barthomeuf et al.,2008,Colon,DLD1,48,Umbelliprenin,27.3,70.98,4.02,3,100,2.29,3
56,Barthomeuf et al.,2008,Breast,MCF-7,48,Umbelliprenin,27.3,62.67,3.68,3,100,2.29,3
56,Barthomeuf et al.,2008,Ovarian,PA1,48,Umbelliprenin,27.3,55.04,3.67,3,100,2.29,3
56,Barthomeuf et al.,2008,Melanoma,M4Beu,48,Umbelliprenin,27.3,3.66,1.84,3,100,2.29,3
56,Barthomeuf et al.,2008,Prostate,PC3,48,Umbelliprenin,27.3,38.07,3.21,3,100,2.29,3
56,Barthomeuf et al.,2008,Lung,A549,48,Umbelliprenin,27.3,41.01,3.22,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,20,77.04,2.46,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,40,65.3,2.45,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,60,54.09,1.1,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,80,42.89,2.19,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,100,34.15,1.09,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,120,26.77,1.37,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,140,19.39,2.19,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,20,67.87,1.33,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,40,47.15,1.55,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,60,38.08,0.8,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,80,36.01,1.03,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,100,31.86,1.55,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,120,21.5,1.81,3,100,2.29,3
57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,140,14.24,1.56,3,100,2.29,3
58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,3.13,83.33,5.72,3,99.5,2.49,3
58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,3.13,72.13,1.5,3,100,1,3
58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,3.13,66.16,3.98,3,99.25,2.24,3
58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,6.25,63.68,2.73,3,99.5,2.49,3
58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,6.25,54.71,2.5,3,100,1,3
58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,6.25,52.83,4.04,3,99.25,2.24,3
58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,12.5,34.82,3.73,3,99.5,2.49,3
58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,12.5,32.58,2.74,3,100,1,3
58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,12.5,30.09,5.48,3,99.25,2.24,3
58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,25,24.37,1.99,3,99.5,2.49,3
58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,25,22.13,6.97,3,100,1,3
58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,25,20.14,2.99,3,99.25,2.24,3
58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,50,14.67,2.49,3,99.5,2.49,3
58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,50,12.68,2.24,3,100,1,3
58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,50,10.19,3.98,3,99.25,2.24,3
58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,3.13,89.61,5.55,3,99.51,2.42,3
58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,3.13,83.81,1.69,3,100,1.29,3
58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,3.13,77.29,4.11,3,99.51,2.18,3
58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,6.25,74.39,3.14,3,99.51,2.42,3
58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,6.25,71.98,2.41,3,100,1.29,3
58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,6.25,63.52,3.87,3,99.51,2.18,3
58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,12.5,67.87,3.86,3,99.51,2.42,3
58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,12.5,60.86,2.42,3,100,1.29,3
58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,12.5,60.86,6.28,3,99.51,2.18,3
58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,25,44.92,1.45,3,99.51,2.42,3
58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,25,42.59,6.68,3,100,1.29,3
58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,25,40.09,3.14,3,99.51,2.18,3
58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,50,24.87,2.18,3,99.51,2.42,3
58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,50,23.07,2.77,3,100,1.29,3
58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,50,15.45,3.87,3,99.51,2.18,3
61,Gkionis et al.,2021,Breast,MCF-7,48,Umbelliprenin,98,50,5.61,2,100,2.29,2
61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,88,50,5.61,2,100,2.29,2
61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,0.1,99.68,5.61,2,100,2.29,2
61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,1,89.71,14.65,2,100,2.29,2
61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,10,101.55,4.05,2,100,2.29,2
61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,50,95.01,6.54,2,100,2.29,2
61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,100,40.8,3.74,2,100,2.29,2
67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,13.67,50,2.28,3,100,1.72,3
67,Zhang et al.,2015,Cervical,HeLa,24,Umbelliprenin,75.83,50,2.28,3,100,1.72,3
67,Zhang et al.,2015,Lung,A549,24,Umbelliprenin,121.53,50,2.28,3,100,1.72,3
67,Zhang et al.,2015,Prostate,PC3,24,Umbelliprenin,88.27,50,2.28,3,100,1.72,3
67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,6.25,87.72,1.43,3,97.72,1.72,3
67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,12.5,80.86,2.28,3,97.72,1.72,3
67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,25,71.43,2.57,3,97.72,1.72,3
67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,50,48,7.14,3,97.72,1.72,3
67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,100,20,2,3,97.72,1.72,3